ArticleMedicine2017
Erratum: Assessment of hepatocellular carcinoma risk based on peg-interferon plus ribavirin treatment experience in this new era of highly effective oral antiviral drugs: Erratum.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.